Scholarly Index
Éric Vivier
Inserm; 61,002 total citations; 506 total publications; best world rank #12
Inserm
61,002Total citations
506Total publications
124H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Immune Cell Function and Interaction | Lifetime | 38 | FR 2 | 99.94 |
| IL-33, ST2, and ILC Pathways | Lifetime | 12 | FR 1 | 99.79 |
| T-cell and B-cell Immunology | Lifetime | 54 | FR 1 | 99.87 |
| CAR-T cell therapy research | Lifetime | 70 | FR 4 | 99.69 |
| Eosinophilic Esophagitis | Lifetime | 141 | FR 6 | 99.12 |
| Galectins and Cancer Biology | Lifetime | 125 | FR 4 | 98.32 |
| Reproductive System and Pregnancy | Lifetime | 344 | FR 10 | 98.08 |
| Inflammation biomarkers and pathways | Lifetime | 884 | FR 44 | 70.02 |
| Immune Cell Function and Interaction | 2021-2025 | 34 | FR 3 | 99.21 |
| T-cell and B-cell Immunology | 2021-2025 | 29 | FR 1 | 98.68 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 13 | FR 1 | 98.43 |
| CAR-T cell therapy research | 2021-2025 | 241 | FR 13 | 98.33 |
| Eosinophilic Esophagitis | 2021-2025 | 127 | FR 2 | 96.96 |